Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Ceridian to Acquire eloomi Revolutionizing People Development

Elaine Mendonca by Elaine Mendonca
January 18, 2024
in Breaking News
0
Technology Data analytics Stock Bull Market
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Ceridian, a leading human capital management company, has recently announced its plans to acquire eloomi, a cutting-edge learning and development platform. This strategic move is set to be finalized in the first quarter of 2024 and will be financed using Ceridian’s existing cash reserves. By joining forces with eloomi, Ceridian aims to revolutionize the people development capabilities of its renowned Dayforce platform, offering customers a truly immersive and enriching learning journey. While the exact financial details of this acquisition remain undisclosed at this time, it is clear that Ceridian is committed to investing in innovative solutions to empower individuals and organizations to thrive.

CDAY Stock Performance on January 18, 2024: Steady Rise and Analysis

On January 18, 2024, CDAY, the stock of human capital management software company Ceridian, showed a steady rise in its performance. According to data sourced from CNN Money, CDAY was trading in the middle of its 52-week range and below its 200-day simple moving average. The price of CDAY shares increased by $0.32 since the market last closed, representing a rise of 0.49%. CDAY opened at $65.70 on January 18, 2024, which was $0.74 higher than its previous close. Trading in the middle of its 52-week range means that CDAY’s stock price was not at its highest or lowest point over the past year. Furthermore, CDAY was trading below its 200-day simple moving average. Overall, CDAY’s stock performance on January 18, 2024, showed a steady rise.

CDAY Stock Performance on January 18, 2024: Mixed Results Raise Concerns about Profitability

CDAY Stock Performance on January 18, 2024:

Total revenue for CDAY stood at $1.25 billion over the past year, marking a significant increase of 21.68% compared to the previous year. However, CDAY’s total revenue for the third quarter of the year was $377.50 million, showing a more modest increase of 3.17% since the previous quarter.

CDAY reported a net income of -$73.40 million over the past year, which is a decrease of 2.65% compared to the previous year. In the third quarter, the net income was -$3.80 million, representing a significant decrease of 222.58% compared to the previous quarter.

CDAY’s EPS over the past year was -$0.48, indicating a 4.27% increase compared to the previous year. However, the third quarter of 2023 saw a significant decrease in EPS, with a value of -$0.02, which represents a decline of 223.86% compared to the previous quarter.

These figures suggest that CDAY has experienced mixed results in terms of financial performance. While the company has managed to increase its total revenue over the past year, the decline in net income and EPS raises concerns about its profitability.

It is important for investors to carefully analyze these numbers and consider other factors before making any investment decisions. Stock performance is influenced by various factors, and thorough research and professional advice are essential for making informed investment decisions.

Tags: CDAY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Government Stock Market Today

Los Angeles County Partners with Genasys to Revolutionize Evacuation Management and Public Safety

Approval of Thermage FLX and TR4 Return Pad by Chinas NMPA Marks Milestone for Solta Medicals Growth in Chinese Market

Visionary Education Group and Algoma University Partner to Foster International Understanding and Academic Collaboration

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com